At the end of August 2019, CRRAB was represented at the International Society for Genetic Eye Diseases & Retinoblastoma (ISGEDR) conference in Giessen, Germany. Ivana Ristevski (Parent in Research), Ana Janic and Stephanie Nanos presented their posters on Patient Engagement research.

CRRAB at ISGEDR from Left to Right: Dr. Brenda Gallie, Ivana Ristevski, Ana Janic, Stephanie Nanos, Dr. Helen Dimaras & Dr. Sameh Soliman

If you’re on twitter, please feel free to check out presentations from our international colleagues with @isgedr or #ISGEDR2019.

Save the Date!

The fourth annual Canadian Retinoblastoma Research Symposium & Research Advisory Board meeting will be held in Toronto on
January 25 & 26, 2020.

The purpose of this free meeting is to bring together people affected by retinoblastoma (i.e., patients and families), health professionals, researchers and policy makers to discuss retinoblastoma research.

More information about the meeting will be made available later 2019.

This video offers an overview of CRRAB: who we are, what we have accomplished, and our future directions. The footage was captured at our annual Retinoblastoma Research Symposium on January 26 & 27, 2019 in Toronto, CA. A taste of what you’d be in for in 2020!

Steeves Lab @ York University

For over 25 years, Professor Jennifer Steeves has been studying the long-term consequences of losing one eye early in life on behaviour and the brain. She began by asking seemingly simple questions like “how well can someone see when they have only one eye compared to someone with two?” This is an important question for a few reasons. First, when a person views the world with one eye rather than two, they lose about a ¼ of the visual field in front of them so their viewing landscape is essentially slightly smaller. Second, when viewing with one eye a person can’t take advantage of the perception of 3-dimensional depth from “stereopsis” where the brain is able to create 3D relief from the different perspectives that the two eyes have of the world. (This is the “jumping out” depth that you would see at an Imax 3D movie.) Third, viewing with one eye means that you have half of the sensory information coming into your visual system.

The final consideration as to why it’s important to study vision in people with one eye is that the surgical removal of the eye (enucleation) for unilateral (one eye) retinoblastoma typically happens at a very young age since that is often when retinoblastoma is discovered. Why is this important? This is because vision is not mature when we are born and it takes many years (even decades) for different aspects of vision to mature to adult levels. The brain is actually not mature at birth and the parts of the brain that allow for vision are still developing and maturing. So the question becomes, how does vision mature when someone has one eye? Specifically, what happens to all of the brain cells in the visual parts of the brain that should have been receiving signals from the eye that was surgically removed? Do they just lie dormant or perhaps just die off or, are they taken over by the eye that remains in order to give it “superpower”?

Dr. Krista Kelly

Jennifer’s lab started off by examining how good vision is with one eye compared to people with two. She compared vision to people with two eyes when they viewed with both eyes or when they viewed with one eye covered. The short story is that for the most part, vision with one eye is really very good, and in some instances, it is actually better than people who have two eyes, even with both eyes open! This was particularly the case for something called “contrast sensitivity” which essentially measures how well we can see fine detail that is very faint. Jennifer’s lab also examined how well people with one eye see motion in the world. This is where there were small shortfalls in the ability to see. People with one eye sometimes had minor difficulties with seeing how things move, although it doesn’t appear to affect daily life since it is very subtle. Her lab suspects that the parts of the brain that allow us to see motion may be developed on a similar timeline to and linked to the ability to see 3D depth. A lot of this research was done with Dr. Krista Kelly who is now a researcher at the Retina Foundation of the Southwest in Dallas, Texas where she is now studying amblyopia.

This cartoon of something called a “contrast sensitivity functions” shows how well we are able to see things that are big and dark compared to faint and tiny. People with one eye were better able to see the faint things compared to people with two eyes.

Jennifer and Krista then began asking questions like “what happens to all of those brain cells that would have been connected to the eye that was surgically removed?” They performed some brain imaging experiments using magnetic resonance imaging also known as MRI. They took some very high resolution images of the brain and essentially they found that some of the parts of the brain that are dedicated to vision are actually bigger than they should be given that people have only one eye. This indicates that the brains of people with one eye have actually rewired and taken over some of the cells in the visual parts of the brain that were disconnected from the eye that was surgically removed. This is also called “brain plasticity”. Jennifer and Krista think that having these “extra” when a person has one eye probably is what allows them to see so well! See for example Kelly et al., Neuroimage Clinical 2014 .

Another interesting finding that Krista and Jennifer noted was that some of the hearing (auditory) parts of the brain also appeared to be bigger than those in the brains of people with two eyes. These bright blue spots painted on this inflated brain show auditory regions of the brain that are thicker in people with one eye compared to people with two eyes. (from Kelly et al., Neuroimage Clinical 2014, available here)

This led to some new questions, specifically “how well do people with one eye hear?” Working with Dr. Adria Hoover (left below), Jennifer’s lab showed that people with one eye are better able to locate sound in space. In a similar vein, Dr. Stefania Moro (right below) conducted a number of studies in Jennifer’s lab and she found that while people with two eyes often are susceptible to illusions where vision dominates over (or captures) hearing, people with one eye are less susceptible to these audio-visual illusions. One of these illusions is called the “McGurk Effect”. In this example, people look at a computer screen at a person is mouthing the vowel “ga” while the vowel “ba” is being played on a speaker. People with two eyes tend to hear a completely different (intermediate) vowel such as “da”. In the laboratory, Jennifer and Stefania showed that people with one eye are less susceptible to such distortions of hearing and that their hearing appears to be more reliable. An example of the McGurk effect can be seen in this video.

Most recently, Stefania and Jennifer are looking at how the visual and auditory parts of the brain function. They have done a number of functional MRI (fMRI) studies to look at how the brain functions when looking at visual objects and hearing different sounds. These results will be coming out soon so stay tuned! 

Overview: The CRRAB Working Groups

1.Patient Engagement Working Group

“Nothing about us, without us”

The CRRAB Patient Engagement Working Group (PEWG) aims to empower retinoblastoma patients to engage in research, to ultimately improve retinoblastoma patient outcomes. This group is made up of retinoblastoma patients, parents, researchers, and clinicians from across Canada who meet once a month to discuss how we can accomplish the goals of the Canadian Retinoblastoma Patient Engagement Strategy:

  • Share research results with people affected by retinoblastoma (e.g., survivor, the immediate family of someone diagnosed with retinoblastoma etc.);
  • Include a large diverse group of people affected by retinoblastoma in research; and
  • Promote research that is created and led by people affected by retinoblastoma.

Primarily, we work to promote the Canadian Retinoblastoma Research Registry, a list of members in the retinoblastoma community, to increase reach of our research engagement opportunities and to ensure patient partners are representative of those affected by retinoblastoma.  

We have also created a network of retinoblastoma patients who act as champions of retinoblastoma research and patient engagement. Our goal is to have a champion leader in each province who collaborates with their local communities to promote retinoblastoma research and CRRAB initiatives.

In addition, the PEWG hosts Retinoblastoma Awareness Tables in the eye clinic at SickKids to introduce patients and parents to CRRAB initiatives, and the Canadian Retinoblastoma Research Registry. Our goal is to host these awareness tables in retinoblastoma clinic across Canada.

To learn more about the PEWG and to share in our passion for research created and led by retinoblastoma patients, join our working group, please email us at

2. Research Advisory Working Group

The Research Advisory Working Group was developed to answer the question: “How do we facilitate ethical and equitable interactions between researchers and patients?”

In this working group, participants review requests from research teams who wish to recruit participants for relevant retinoblastoma studies through the Canadian Retinoblastoma Research Registry. The request is vetted by the Research Advisory Working Group and a lay summary of the request to participate is emailed to the registry participants who have expressed interest in being contacted for research opportunities.  

This working group creates this very quarterly newsletter and corresponding blog ( that includes articles co-written by researchers and patients about new research, retinoblastoma conferences, or experiences with patient engagement in research projects. The group is currently updating the website to better highlight the great work CRRAB is doing – stay tuned for the big reveal!

3. Research development working group

This working group evolved from a previous working group focused determining the top 10 retinoblastoma research priorities in Canada. Their goal is to design a research proposal based on one of the Top 10 priorities. The Research Development Working Group members are working towards solving Priority 3:

How to provide culturally competent social, emotional and psychosocial support to retinoblastoma patients, survivors, parents and families (at diagnosis
and beyond)

The members created the study protocol and have applied to grant competitions that are currently under review. See our previous post about this project here.

Upcoming: Calgary RB Family Day

Author: Leslie Low, retinoblastoma parent

Families in Western Canada are invited to attend a Retinoblastoma Family Day. Event will be held on October 5, 2019 from 10am-4pm. This is a great opportunity to connect with other retinoblastoma families!

Morgan Livingstone (child life specialist) is flying out from Toronto to run a child life program – this is a great opportunity to help kids learn to be more comfortable with their condition and procedures. While the Child Life program is running, we will have a robust education session for the adults. Several retinoblastoma experts have agreed to come and share their wisdom including Dr Gallie (ophthalmologist), Dr Ronald Anderson (oncologist), and Shirley Weyland (occularist). We will be discussing important topics such as second cancers, pathway of care for treatment (especially when the trips to Toronto become less frequent), and how we as patients can help drive the research forward and provide a better future for retinoblastoma. Any person who has been impacted by retinoblastoma is welcome to attend!

Click here to register